Abstract: Provided are a method for preparing liposomes comprising ultrasound reactive microbubbles for drug delivery, comprising (a) a step of producing ultrasound reactive microbubbles comprising an inert gas therein and having a first shell formed on the outer surface thereof, followed by forming a uniform size distribution of the ultrasound reactive microbubbles through an extruder; and (b) a step of producing liposomes comprising the ultrasound reactive microbubbles distributed in a uniform size and a medicament therein and having a second shell formed on the outer surface thereof, followed by forming a uniform size distribution of the liposomes through an extruder; and a liposome using same.
Type:
Grant
Filed:
March 20, 2019
Date of Patent:
November 22, 2022
Assignees:
BIOINFRA LIFE SCIENCE INC., PACIFIC SYSTEM CO., LTD.
Inventors:
Chui Woo Kim, Dong Hee Park, Jong Ho Won
Abstract: A computing device of the present invention estimates an unknown parameter ? of a model formula when distributed sample data is acquired, wherein when an estimated quantity of ? is acquired, a function g is estimated using a random forest model, such that when an estimated quantity of g is acquired, the estimated quantity of g and the estimated quantity of ? are used so as estimate a function G as a prediction formula for new data corresponding to a specific item such that an estimated quantity of G is acquired, and thus new data xnew is received, thereby enabling the class of the specific item to be classified from the calculated value.
Type:
Grant
Filed:
November 9, 2017
Date of Patent:
October 4, 2022
Assignee:
BIOINFRA LIFE SCIENCE INC.
Inventors:
Chul Woo Kim, Yong Dai Kim, Kyung Nam Kang, Oh Ran Kwon
Abstract: A method for diagnosing lung cancer in a subject by using a complex biomarker group is provided. The method includes steps of: (a) a computing system (1) acquiring a model M by using expression level data by individual biomarkers in the complex biomarker group and then (2) acquiring expression level data by the individual biomarkers measured from a biological specimen of the subject or their processed data Bk; and (b) the computing system determining whether lung cancer is detected in the subject by using the acquired data of the subject by referring to the model M; wherein the complex biomarker group includes CEA, HE4, ApoA2, TTR, sVCAM-1 and RANTES.
Type:
Grant
Filed:
February 10, 2017
Date of Patent:
May 26, 2020
Assignee:
BioInfra Life Science Inc.
Inventors:
Chul Woo Kim, Yong Dai Kim, Yong Sung Shin, Eun Hee Yeon, Kyung Nam Kang, Ho Sang Shin, Oh Ran Kwon